Spero Therapeutics
SPRO
#9370
Rank
โ‚ฌ0.11 B
Marketcap
1,94ย โ‚ฌ
Share price
-2.21%
Change (1 day)
-21.02%
Change (1 year)

EPS for Spero Therapeutics (SPRO)

EPS in 2025 (TTM): -0,73ย โ‚ฌ

According to Spero Therapeutics's latest financial reports the company's current EPS (TTM) is -0,69ย โ‚ฌ. In 2024 the company made an earnings per share (EPS) of -1,11ย โ‚ฌ.

EPS history for Spero Therapeutics from 2017 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-0,73ย โ‚ฌ-34.3%
2024-1,11ย โ‚ฌ
2022-1,46ย โ‚ฌ
2020-3,17ย โ‚ฌ9.39%
2019-2,90ย โ‚ฌ25.48%
2018-2,31ย โ‚ฌ-51.35%
2017-4,75ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
IBM
IBM
10,10ย โ‚ฌ-1,556.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Thomson Reuters
TRI
3,03ย โ‚ฌ-537.13%๐Ÿ‡จ๐Ÿ‡ฆ Canada
Franklin Covey
FC
-0,09657ย โ‚ฌ-86.08%๐Ÿ‡บ๐Ÿ‡ธ USA